# ADMA BIOLOGICS, INC. (ADMA) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from ADMA BIOLOGICS, INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/ADMA/mda/fy2025/): filed 2026-02-25; accession 0001140361-26-006815 (https://www.sec.gov/Archives/edgar/data/1368514/000114036126006815/ef20059416_10-k.htm); latest 10-K
- [FY 2024 MD&A](/company/ADMA/mda/fy2024/): filed 2025-03-18; accession 0001140361-25-009257 (https://www.sec.gov/Archives/edgar/data/1368514/000114036125009257/ef20038923_10k.htm)
- [FY 2023 MD&A](/company/ADMA/mda/fy2023/): filed 2024-02-28; accession 0001140361-24-010147 (https://www.sec.gov/Archives/edgar/data/1368514/000114036124010147/ef20015264_10k.htm)
- [FY 2022 MD&A](/company/ADMA/mda/fy2022/): filed 2023-03-23; accession 0001140361-23-013467 (https://www.sec.gov/Archives/edgar/data/1368514/000114036123013467/brhc10049985_10k.htm)
- [FY 2021 MD&A](/company/ADMA/mda/fy2021/): filed 2022-03-24; accession 0001140361-22-011030 (https://www.sec.gov/Archives/edgar/data/1368514/000114036122011030/brhc10035480_10k.htm)

Back to /company/ADMA/